Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care

2021-12-23T17:10:33+01:00

Contributo: Stefania Camastra Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care Aminian A, Wilson R, Zajichek A, Tu C, Wolski KE,

Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care2021-12-23T17:10:33+01:00

Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain

2021-12-23T17:21:10+01:00

Contributo: Guzzardi Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain Rinott E. et al. Gastroenterology. 2021; 160(1): 158–173.e10. doi:10.1053/j.gastro.2020.08.041.   Effetto del trapianto autologo di microbiota fecale modulato dalla dieta sul

Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain2021-12-23T17:21:10+01:00

Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care

2021-12-16T20:02:08+01:00

Contributo: Stefania Camastra Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual CareAminian A, Wilson R, Zajichek A, Tu C, Wolski KE, Schauer

Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care2021-12-16T20:02:08+01:00

METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL.

2021-12-16T19:43:13+01:00

Contributo: Maurizio De Luca METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL. G Mingrone, S Panunzi, A De Gaetano,

METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL.2021-12-16T19:43:13+01:00

Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness

2017-12-18T17:59:54+01:00

Contributo di GORTAN CAPPELLARI Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness Nicholas M Morton et al., Nature Medicine 22, 771–779, 2016, doi:10.1038/nm.4115

Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness2017-12-18T17:59:54+01:00

LOGIN SOCI

Torna in cima